Activation of the NF-κB pathway has been shown to downregulate SGK1 expression29; herein, the expression of NF-κB p65 was significantly upregulated in the VEO or primary VRML cells from patients with MD compared that in patients with AN (Supplementary Fig. 1e, f). This evidence concerns the gene SGK1 and Menkes disease.